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Abstract 
Background: Deposition of aggregated amyloid beta (Aβ) protein is hallmark of Alzheimer’s disease, leading to 
dysfunction and apoptosis of neurons. The isoflavone phytoestrogen compound genistein (Gen) exerts a significant 
protective effect against Aβ25–35 induced neurotoxicity and mitochondrial damage in rat pheochromocytoma (PC12) 
cells. However, the mechanisms underlying Gen’s rescue remain elusive. Therefore we endeavored to research further 
the molecular mechanisms underlying Gen’s inhibition of Aβ25–35 induced apoptosis of neurons.
Results: We found that Gen dramatically suppressed the activation by Aβ25–35 of p-c-Jun N-terminal kinase (p-JNK), 
and also inhibited the JNK-dependent decreased of Bcl-w and increased of Bim. Furthermore, Gen significantly 
reduced the cytoplasmic concentrations of cytochrome c and Smac protein as well as caspase-3 activity. Additionally, 
pretreatment with JNK inhibitor SP600125 effectively suppressed Aβ25–35 induced PC12 cell cytotoxicity.
Conclusion: Taken together, the results suggested that Gen protects PC12 cells from Aβ25–35 induced neurotoxic-
ity by interfering with p-JNK activation, thus attenuating the JNK-dependent apoptosis through the mitochondrial 
pathway. These findings constitute novel insights into the pathway for Aβ25–35 toxicity, and the neuroprotective action 
of Gen.
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Background
The amyloid β protein is a β-sheet peptide compose by 
39–43 amino acid residues; its fragment Aβ25–35 (GSNK-
GAIIGLM), the smallest fragment formed by brain pro-
teases, retains the toxicity of the parent peptide as well 
as a capacity to form aggregates in vivo. As such, Aβ25–35 
promotes to the development of Alzheimer’s disease 
(AD) pathology and the resultant clinical symptoms [1, 
2]. Deposition of Aβ25–35 in brain triggers tau protein 
phosphorylation and formation of intracellular neurofi-
brillary tangles (NFT), subsequently leading to mito-
chondrial dysfunction and membrane rupture, which 
then proceeds to necrosis or apoptosis [3]. As such, by 
investigating the pathway by which Aβ25–35 toxicity leads 
to neuronal apoptosis we may understand the develop-
ment of new treatment strategies in AD.
Extensive research has shown that Aβ25–35 accumula-
tion is linked with many signaling pathways implicated in 
neurodegenerative disease. In particular, c-Jun N-termi-
nal kinase (JNK) is a factor in Aβ induced apoptosis of 
neurons [4]. JNK regulates many transcription factors, 
including the Bcl-2 family [5], which importantly con-
trols of the mitochondria apoptosis pathway [6]. Finally, 
the release of the mitochondrial proteins cytochrome c 
and second mitochondrion-derived activator of caspase 
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Genistein (Gen) is an isoflavone phytoestrogen derived 
from soybeans. It is present in tofu (soybean curd) and 
its consumption has shown promising results as a mod-
erator of cognitive deficits in AD [8]. Indeed, substan-
tial evidence suggests that Gen inhibits Aβ25–35-induced 
toxicity via regulation of many relevant signaling path-
ways [9–11] and by facilitation of Aβ clearance from the 
nervous system [12]. Conversely, another study showed 
that dietary Gen can lead to cognitive impairment [13]. 
Resolving these contradictory findings requires a better 
understanding of the molecular mechanisms whereby 
Gen modulates AD neuropathology. However, differen-
tiated neuron-like rat pheochromocytoma (PC12) cells 
often used for studying neuroprotection [14, 15].
Given this background, we endeavored to use PC12 
cells in order to test whether Gen protects PC12 cells 
from Aβ25–35 induced neurotoxicity. In particular, we 
researched the regulatory effects of Gen on the expres-
sion of Bcl-2 family members (such as the Bcl-w and 
Bim) in PC12 cells challenged with Aβ25–35 in  vitro. 
Furthermore, we also examined the effects of Gen on 
the JNK phosphorylation level upstream in the mito-
chondrial apoptotic pathway. Our studies in PC12 cells 
address fundamental aspects of the potential of Gen to 




PC12 cells were obtained from the Institute of Biochem-
istry and Cell Biology (Shanghai, China) cell bank and 
cultured in Roswell Park Memorial Institute (RPMI) 
1640 medium supplemented with 10% v/v fetal bovine 
serum (FBS), 100 U/mL penicillin, and 0.1 mg/mL strep-
tomycin (all from Hyclone, Logan, UT) at 37  °C in a 
humidified atmosphere of CO2 (5%). After every second 
day, replaced with fresh media, to promote growth until 
the cells reach a confluence of 70–80%.
Determination of cell viability
MTT was used to detect viability of PC12 cells. In brief, 
the cells were cultured in medium at a density 5 ×  104 
cells per well for 24  h in 96-well plates and then pre-
treated with or without Gen at final concentrations of 
12.5, 25, 50, and 100 μM for 2 h and incubated with Aβ25–
35 (20 μM) for another 24 h. The Aβ25–35 (Sigma-Aldrich) 
was first dissolved in tri-distilled water at a concentration 
of 1 mM, and then aged for 3 days in a humidified cham-
ber at 37 °C before being added to the culture medium to 
the final desired concentration. Cells were added to 10 μL 
of MTT solution medium (5  mg/mL) and then incu-
bated at 37  °C for 4  h. The medium was then carefully 
removed, and added 150 μL per well DMSO to dissolve 
the formazan crystals formed in  situ. Cell viability was 
then determined by measuring the absorbance of each 
well at 570  nm using a microtiter plate reader (Biotek, 
VT). Each concentration was repeated three times with 
five replicates per experiment.
Hoechst 33342 staining to detect cell apoptosis
Hoechst 33342 (Beyotime Biotechnology, Haimen, 
China) was used to identify the apoptotic cells. PC12 
cells were cultured and then pretreated with Gen at con-
centrations of 12.5, 25, 50, and 100 μM for 2 h and incu-
bated with Aβ25–35 (20 μM) for another 24 h. Cells were 
washed with PBS and then stained with Hoechst 33342 
DNA-binding dye (10 mg/L) for 15 min at 37 °C in dark-
ness. Finally, the cells were washed with PBS and exam-
ined under a fluorescence microscope (Leica, Germany).
Fluorescence‑activated cell sorting (FACS) analysis
PC12 cells were cultured in 6-well plates; treated with 
12.5, 25, 50, and 100  μM of Gen for 2  h; and finally 
incubated with Aβ25–35 (20  μM) for another 24  h. Cell 
apoptosis was measured using the Annexin V-FITC 
Apoptosis Detection Kit I (Beyotime Biotechnology, 
Haimen, China). In brief, the cells were washed once 
with PBS and digested with trypsin. The subsequently 
collected cells were washed once with PBS. Next, 5  μL 
of Annexin V-FITC and 10 μL of propidium iodide (PI) 
were then added according to the manufacturer’s instruc-
tions. And mixing and incubation for 10 min in darkness 
at room temperature, cells were detected using a FACS 
(BD Biosciences, San Jose, CA).
RNA extraction and real‑time RT‑PCR quantitation
PC12 cells were treated with Gen at concentrations of 
25 μM for 2 h and with the JNK phosphorylation inhibi-
tor SP600125 (Beyotime Biotechnology, Haimen, China) 
at a concentration of 100  nM for 1  h; finally incubated 
with Aβ25–35 (20  μM) for another 24  h. Total RNA was 
then isolated from the PC12 cells with Trizol reagent 
(Invitrogen, Carlsbad, CA). RNA concentration and 
purity were determined using a fluorospectrophotom-
eter (RF-5301PC; Shimadzu, Japan), and RNA integrity 
was verified by 1% agarose gel electrophoresis. The first 
strand cDNAs were synthesized from 2 μg of total RNA 
in a 20  μL reaction volume using reverse transcriptase 
(Takara Biotechnology, Dalian, China).
Next, 2 μL portions of the reverse transcription prod-
uct was amplified with the SYBR® Premix Ex Taq™ 
II (Tli RNaseH Plus) (Takara Biotechnology, Dalian, 
China). The special primers were designed from their 
GenBank sequences and synthesized by Bio Basic Inc. 
(Shanghai, China): 5′-CACTTTCTACAATGAGCTGC 
G-3′, 5′-CTGGATGGCTACGTACATGG-3′ for β-actin; 
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5′-GAGTTTGAGACCCGCTTCC-3′, 5′-GTCCTCACT 
GATGCCCAGTT-3′ for Bcl-w; and 5′-CTTACACGAGG 
AGGGCGTTT-3′, 5′-CAGTGCCTTCTCCAGACCA 
G-3′ for Bim. The thermal profile reactions were per-
formed in a real-time PCR system (Bio-Rad, Hercu-
les, CA), and the amplified products were quantified by 
measuring the calculated cycle thresholds (CT) for indi-
vidual targets and the β-actin reference mRNA. The 2−
ΔΔCT method was used for quantification and statistical 
analysis.
Western blots
Cytoplasmic proteins were isolated using a Cytoplasm 
Protein Extraction Kit. Thereafter, a BCA Protein Assay 
Kit (Beyotime Biotechnology, Haimen, China) was used to 
determine the protein concentrations. The samples were 
boiled for 5  min. Next, portions containing 20  μg pro-
tein were separated on 12% SDS–polyacrylamide gel and 
transferred onto PVDF membranes (Millipore, Bedford, 
MA) at a current of 200  mA for 40  min. After blocking 
for 2  h in a TBS containing 0.1% Tween 20 (TBST)  and 
5%  w/v skim milk powder at room temperature, these 
membranes were incubated overnight at 4  °C with pri-
mary antibodies against β-actin, cytochrome c, and Smac 
(1:300, BOSTER, Wuhan, China), and anti-p-JNK (1:2000, 
Cell Signaling Technology, Danvers, MA), with dilutions 
in TBST. After washing three times with TBST, the mem-
branes were incubated with horseradish peroxidase-con-
jugated secondary antibody (1:5000, BOSTER, Wuhan, 
China) for 1  h at room temperature and again washed 
three or four times. The bands were developed using an 
ECL kit following the manufacturer’s instructions, with 
β-actin serving as a loading control. The X-OMAT BT 
films (Carestream, Xiamen, China) were scanned and 
quantitated using Quantity One software.
Caspase activity assay
To evaluate the activity of caspase-3, cell lysates were 
prepared after their various respective treatments. Assays 
were performed on 96-well plates by incubating 10  μL 
portions of cell lysate per sample in 80 μL reaction buffer 
[0.1% Nonidet P 40, 20 mM Tris-HCl (pH 7.5), 137 mM 
NAD, and 10% glycerol] containing 10 μL caspase-3 sub-
strate (2 mM, Ac-DEVD-pNA) following the manufactur-
er’s instructions. Lysates were incubated in this medium 
at 37 °C for 2 h, and absorbance measured at 405 nm with 
the microtiter plate reader (Biotek, VT).
Statistical analyses
Data were expressed as mean ±  SD, and all determina-
tions were repeated three times. The data were analyzed 
by using SPSS v20.0 software (SPSS Inc., Chicago, IL), 
and p < 0.05 were considered statistically significant.
Results
Effect of Gen on viability of PC12 cells
The MTT assay showed that Gen (0–25  μM) alone had 
no adverse effects on PC12 cells viability, but 50 and 
100  μM decreased viability compared with the con-
trol group (p  <  0.05) (Fig.  1a). Incubation with Aβ25–
35 significantly increased PC12 cells apoptosis in a 
Fig. 1 Effect of Gen on the viability of PC12 cell. a Viability of 
PC12 cell treatment with Gen (0, 12.5, 25, 50, and 100 μM) for 24 h. 
*p < 0.05 compared to control. b Dose-dependent change of cell 
viability of PC12 cells by Aβ treatment for 24 h and 48 h. *p < 0.05 
compared to control. c Prevention of Aβ25–35-induced cell death by 
Gen. Cells were pretreated with Gen for 2 h followed by exposure 
to 20 μM Aβ25–35 for 24 h. 
#p < 0.05 compared to control; *p < 0.05 
compared to model group. Cell viability was evaluated by MTT assay. 
Values were expressed as mean ± SD
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dose-dependent manner at concentrations up to 20 μM, 
with no further increase at 80  μM (Fig.  1b). PC12 cells 
pretreated with Gen for 2 h prior to Aβ25–35 incubation 
indicated a bell-shaped effect of Gen on the viability of 
PC12 cells (Fig.  1c), with significant rescue at low Gen 
concentrations.
Hoechst 33342 staining to detect PC12 cells apoptosis
Hoechst 33342 staining showed that the percentage of 
apoptotic cells in media containing Aβ25–35 was dra-
matically increased compared with the normal group . 
However, Gen pretreatment significantly decreased the 
apoptosis rate compared with the Aβ25–35 group (Fig. 2).
Using FACS to detect PC12 cells apoptosis
The rate of cell apoptosis was measured by labeling cells 
with annexin-V-FITC/PI (Fig.  3a). Quantitative analysis 
of Annexin V-positive cells indicated that treatment cells 
with Aβ25–35 (20 μM) for 24 h significantly increased cell 
apoptosis, but that Gen pretreatment at 12.5–100  μM 
markedly decreased cell apoptosis, with the maximal 
protective effects seen with 25 μM Gen (Fig. 3b). Based 
Fig. 2 PC12 cells were stained with the DNA-binding fluorochrome Hoechst 33342. a Fluorescence micrographs of PC12 cells from control group, 
pretreated with Gen (0, 12.5, 25, 50, 100 μM) for 2 h followed by incubation with 20 μM Aβ25–35 for another 24 h (scale bar 100 μm). b The percent-
age of PC12 cells with apoptosis was estimated. *p < 0.05 compared to control; #p < 0.05 compared to Aβ25–35 alone
Fig. 3 Gen pretreatment attenuation Aβ25–35-induced cell apoptosis. a Annexin-V-FITC/PI double staining of PC12 cells. b The bar chart describes 
the percentage distribution of apoptotic cells. Percentage of annexin-V-positive cells analysis of FACS obtained from three separate experiments 
and are expressed as mean ± SD, n = 3. *p < 0.05 compared to control; #p < 0.05 compared to Aβ alone
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on these results, we used 20 μM Aβ25–35 and 25 μM Gen 
in subsequent experiments.
Gen reduced Aβ25–35 induced Bcl‑w mRNA decreased 
and Bim increased
We examined the effects of Aβ25–35 on mRNA expres-
sion for Bcl-w and Bim, two major members of the Bcl-2 
family that modulate mitochondrial apoptosis in oppos-
ing manners. Our RT-qPCR results (Fig. 4) showed that 
Aβ25–35 dramatically decreased Bcl-w and increased Bim 
mRNA levels, and that these changes were significantly 
reversed by Gen pretreatment. Furthermore, the JNK 
inhibitor SP600125 significantly attenuated the changes 
of Bcl-w and Bim mRNA expression induced by Aβ25–35.
Gen attenuated release of cytochrome c and Smac induced 
by Aβ25–35
Cytochrome c and Smac are released from mitochondria 
to the cytoplasm when mitochondrial apoptosis occurs. 
Western blots showed increased cytochrome c and Smac 
protein levels in PC12 cells incubated with Aβ25–35. How-
ever, pretreatment with Gen significantly attenuated 
this increase, as did incubation with the JNK inhibitor 
SP600125 (Fig. 5).
Effect of Gen on regulation of Aβ25–35 induced activity 
of caspase‑3 and JNK
Caspases are key players in the apoptotic process and 
play a crucial role in the execution of mitochondria-
mediated apoptosis. Results (Fig.  6) showed that Gen 
significantly inhibited the activation of caspase-3 activity 
in PC12 cells induced by Aβ25–35. Western blot results 
(Fig.  7a) showed that Aβ25–35 significantly increased the 
p-JNK level in PC12 cells. However, Gen pretreatment 
blocked the Aβ25–35-induced p-JNK expression, whereas 
co-incubation with the JNK inhibitor SP600125 potenti-
ated the inhibitory effect of Gen on Aβ25–35 induced JNK 
phosphorylation (Fig. 7b).
Discussion
Aβ aggregation and formation of intracellular compo-
nents of senile plaques (SP) and NFT are key steps during 
the pathological process of neurodegenerative disease. 
In  vitro studies showed that the overexpression and 
aggregation of Aβ is an initiator of neuronal degenera-
tion [16], and intracerebral Aβ injection provokes neu-
ronal damage [17]. The active Aβ proteolytic fragment 
Aβ25–35 retains the capacity to induce neuronal apoptosis, 
although uncertainty about the relevant signaling path-
ways has hindered the development of specific targeted 
treatments; this motivated the present investigation of 
the interaction between the phytoestrogen Gen and Aβ 
toxicity.
The process of programmed cell death through activa-
tion of distinct signaling pathways, including the mito-
chondrial apoptotic pathway [18]—a cascade which is 
involved in Aβ neuronal toxicity [19]. The mitochondrial 
apoptotic pathway is initiated by members of the Bcl-2 
family. Among these, Bcl-w is widely expressed in mam-
malian tissues, particularly mature brain [20]. Over-
expression of Bcl-w in primary culture neurons [21] 
conferred protection from Aβ-induced apoptosis, thus 
suggesting that Bcl-w may be a constitutive inhibitor of 
apoptosis. In contrast, Bim is a pro-apoptotic member of 
Bcl-2 family, which is reported to upregulate in a variety 
of neuronal death paradigms [22]. Thus, silent inhibition 
of Bim by antisense and genetic knockout approaches can 
markedly decrease apoptosis of neurons [23, 24]. Later 
reports have shown that Aβ25–35 downregulates Bcl-w and 
upregulates Bim [21], and Gen inhibits Aβ25–35 induced 
neurotoxicity via PKC signaling pathway and regulation of 
the CaMKII/CREB pathway [10, 11]. Present results con-
firm our hypothesis that the neuroprotective agent Gen 
should normalize pro-apoptotic alterations in Bcl-w and 
Bim mRNA expression by Aβ25–35.
Cytochrome c—a key constituent of the electron 
transfer chain in cellular respiration [25]—is normally 
confined to the inner mitochondrial membrane. When 
apoptosis signaling causes irreparable mDNA damage, 
cells hosting these mitochondria show increased release 
of cytochrome c into their cytosol, suggesting a mecha-
nistic marker for apoptosis [26, 27]. Therefore, we also 
monitored cytoplasmic levels cytochrome c and Smac 
in Aβ25–35-stressed PC12 cells. As expected, Aβ25–35 
Fig. 4 Effect of Gen on the mRNA of Bcl-w and Bim in PC12 cells 
detected by real-time PCR. PC12 cells were pretreated with or 
without Gen at concentrations of 25 μM for 2 h followed by exposure 
to 20 μM Aβ25–35 for 24 h. SP600125 (100 nM) was added to cultures 
1 h prior to Aβ25–35. Values are expressed as mean ± SD. *p < 0.05 
compared to control; #p < 0.05 compared to Aβ alone
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exposure increased cytosol cytochrome c and Smac, 
whereas pretreatment with Gen rescued PC12 cells from 
these increases, indicating protection of mitochondria. 
Moreover, activity of caspase enzymes play a major role 
in the modulation of apoptosis [28], and histopathology 
shows co-localization of hyperphosphorylated tau pro-
tein and caspases in the brainstem of AD patients [29]. 
In the present study we found that pretreated with Gen 
attenuated the caspase-3 activity induced by Aβ25–35. 
This finding implies that Gen interferes with Aβ induced 
apoptosis in PC12 cells through effects on the mitochon-
drial apoptotic pathway.
JNK activation is closely linked to distinct apoptotic 
stimuli, whereas silencing of JNK signaling can protect 
against apoptosis of neurons [30]. In addition, results of 
studies in vitro and in vivo show that alterations of JNK 
pathways are associated with pathogenesis and apoptosis 
of neurons in AD [31]. Importantly, evidence shows that 
pretreatment with the JNK inhibitor SP600125 prior 
to Aβ25–35 exposure blocked expression of Bcl-2 family 
members, including Bcl-w and Bim [21]. This (in con-
junction with the present results) implies that Gen may 
influence Bcl-2 family expression through JNK signal-
ing. Indeed, these results showed that Gen significantly 
reduced the phosphorylation of JNK, suggesting that 
amelioration by Gen of Aβ25–35-induced changes in the 
mitochondrial apoptotic pathway is mediated by JNK 
activation.
The pharmacological basis of Gen’s effects may be 
related to its estrogenic profile. Bagheria et al. [32] found 
that Gen treatment ameliorated the Aβ induced impair-
ment of short-term spatial memory via an estrogenic 
pathway in rats. Indeed, several studies have shown 
that estrogen can promote the regeneration of stressed 
Fig. 5 Gen reduced cytochrome c and Smac release induced by Aβ25–35 in PC12 cells. PC12 cells were pretreated with or without Gen at concentra-
tions of 25 μM for 2 h followed by exposure to 20 μM Aβ25–35 for 24 h. SP600125 (100 nM) was added to cultures 1 h prior to Aβ25–35. a Cytochrome 
c levels were determined by Western blot analysis with antibody to cytochrome c. b Smac levels were determined by Western blot analysis with 
antibody to Smac. c Quantitated results of Cytochrome c are presented relative to control. d Quantitated results of Smac are presented relative to 
control. Densitometric analysis of Western blot obtained from three separate experiments, and data are expressed as mean ± SD, n = 3. *p < 0.05 
compared to control; #p < 0.05 compared to Aβ alone
Page 7 of 9You et al. BMC Neurosci  (2017) 18:12 
neurons, and can protect neurons from death [33]. More-
over, clinical studies show that postmenopausal women 
treated with estrogen replacement therapy had less mem-
ory deficits compared to women not receiving estrogen 
treatment [34]. An epidemiological survey also showed 
that estrogen replacement therapy was associated 
with significantly reduced risk of AD in aged women. 
However, estrogen therapy is a double-edged sword, 
imparting neuroprotective effects but also increasing the 
risk for neoplastic transformation in certain non-neu-
ronal cell types [35]; this trade-off has limited the use of 
estrogen for protection against dementia in women.
On the other hand, recent studies showed that several 
phytoestrogens such as Gen, puerarin, and tanshinone 
have neuronal protective effects and few side effects, 
thus favoring further investigations into the clinical use 
of these compounds. Researchers have shown positive 
effects of Gen in cancer [36], cognitive dysfunction [10], 
and heart disease [37]. Gen can ameliorate Aβ-induced 
pathology and astrogliosis [38, 39]. Gen has a different 
tissue-specific agonist–antagonist profile than estro-
gen since, while it can be neuroprotective, it does not 
cause cancer in the uterus and other tissues in analogy to 
tamoxifen, which is an antagonist on some tissues but an 
agonist in others. This background motivates the present 
investigation into the neuroprotective attributes of Gen.
Conclusion
Our results are consistent with the hypothesis that Gen 
can attenuate Aβ25–35 induced PC12 cells apoptotic 
through inhibition of Aβ25–35 induced JNK activation, 
JNK-dependent decreased of Bcl-w and increased of Bim, 
along with attenuation of cytochrome c and Smac release 
from the mitochondria, and reduced caspase-3 activity. 
Furthermore, findings upon concomitant treatment with 
JNK inhibitor SP600125 and Gen showed that additional 
factors may mediate resistance to Aβ25–35-triggered 
Fig. 6 Effect of Gen on the activity of caspase-3 in Aβ25–35-treated 
PC12 cells. PC12 cells were pretreated with or without Gen at concen-
trations of 25 μM for 2 h followed by exposure to 20 μM Aβ25–35 for 
24 h. SP600125 (100 nM) was added to cultures 1 h prior to Aβ25–35. 
Values were expressed as mean ± SD. *p < 0.05 compared to control; 
#p < 0.05 compared to Aβ alone
Fig. 7 Gen attenuation Aβ25–35-induced JNK phosphorylation detected by Western blot. PC12 cells were pretreated with or without Gen at con-
centrations of 25 μM for 2 h followed by exposure to 20 μM Aβ25–35 for 24 h. SP600125 (100 nM) was added to cultures 1 h prior to Aβ25–35. a p-JNK 
levels were determined by Western blot analysis with antibody to p-JNK. b Quantitated results of p-JNK are presented relative to control. Densi-
tometric analysis of Western blot obtained from three separate experiments, and data are expressed as mean ± SD, n = 3. *p < 0.05 compared to 
control; #p < 0.05 compared to Aβ alone
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apoptosis. We conclude that Gen—a major active ingre-
dient of soybean isoflavones—possessing a good safety 
profile and merits further investigation as a treatment to 
suppress neuronal apoptosis.
Abbreviations
Gen: genistein; p-JNK: p-c-Jun N-terminal kinase; Aβ25–35: GSNKGAIIGLM; AD: 
Alzheimer’s disease; NFT: neurofibrillary tangles; JNK: c-Jun N-terminal kinase; 
Smac: second mitochondrion-derived activator of caspase; PBS: phosphate 
buffered saline; FACS: fluorescence-activated cell sorting; PI: propidium iodide; 
TBS: tris-buffered saline.
Authors’ contributions
FLY writing of the manuscript. QL, GFJ and YJZ participated in the design of 
the study an analysis of the results. JRC participated in the analysis of the data. 
HY participated in the design of the study, analysis of the data, corrected the 
manuscript and guidance through the project. All authors read and approved 
the final manuscript.
Acknowledgements
This study is supported by the Science and Technology Plan of Social Develop-
ment Projects of Guangdong Province (2012B031800430).
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The data supporting the conclusions of this article are included within the 
article and its Additional file 1.
Funding
No funding.
Received: 11 July 2016   Accepted: 27 December 2016
References
 1. Hellstrom-Lindahl E, Viitanen M, Marutle A. Comparison of Aβ levels in 
the brain of familial and sporadic Alzheimer’s disease. Neurochem Int. 
2009;55(4):243–52.
 2. Basha MR, Murali M, Siddiqi HK, Ghosal K, Siddiqi OK, Lashuel HA, Ge YW, 
Lahiri DK, Zawia NH. Lead (Pb) exposure and its effect on APP proteolysis 
and Aβ aggregation. FASEB J. 2005;19(14):2083–4.
 3. Tabaton M, Piccini A. Role of water-soluble amyloid-beta in the patho-
genesis of Alzheimer’s disease. Int J Exp Pathol. 2005;86(3):139–45.
 4. Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, Davis RJ, 
Shirasaki Y, Greenberg ME. Beta-amyloid induces neuronal apoptosis via 
a mechanism that involves the c-Jun N-terminal kinase pathway and the 
induction of Fas ligand. J Neurosci. 2001;21(19):7551–60.
 5. Yao M, Nguyen TV, Pike CJ. Beta-amyloid-induced neuronal apoptosis 
involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J 
Neurosci. 2005;25(5):1149–58.
 6. Harris MH, Thompson CB. The role of the Bcl-2 family in the regula-
tion of outer mitochondrial membrane permeability. Cell Death Differ. 
2000;7(12):1182–91.
 7. Korga A, Korobowicz E, Dudka J. Role of mitochondrial protein Smac/
Diablo in regulation of apoptotic pathways. Pol Merkur Lekarski. 
2006;20(119):573–6.
Additional file
Additional file 1: The data of the results of mRNA and activity of caspase 
3 and caspase 8.
 8. Thorp AA, Sinn N, Buckley JD, Coates AM, Howe PR. Soya isoflavone 
supplementation enhances spatial working memory in men. Br J Nutr. 
2009;102(9):1348–54.
 9. Liao W, Jin G, Zhao M, Yang H. The effect of genistein on the content and 
activity of alpha- and beta-secretase and protein kinase C in Aβ-injured 
hippocampal neurons. Basic Clin Pharmacol Toxicol. 2013;112(3):182–5.
 10. Luo S, Lan T, Liao W, Zhao M, Yang H. Genistein inhibits Aβ (25–35) 
-induced neurotoxicity in PC12 cells via PKC signaling pathway. Neuro-
chem Res. 2012;37(12):2787–94.
 11. Xi YD, Zhang DD, Ding J, Yu HL, Yuan LH, Ma WW, Han J, Xiao R. Genistein 
inhibits Aβ25–35-induced synaptic toxicity and regulates CaMKII/CREB 
pathway in SH-SY5Y cells. Cell Mol Neurobiol. 2016;36(7):1151–9.
 12. Bonet-Costa V, Herranz-Perez V, Blanco-Gandia M, Mas-Bargues C, Ingles 
M, Garcia-Tarraga P, Rodriguez-Aria M, Minarro J, Borras C, Garcia-Verdugo 
JM, et al. Clearing amyloid-β through PPARγ/ApoE activation by genistein 
is a treatment of experimental Alzheimer’s disease. J Alzheimers Dis. 
2016;51(3):701–11.
 13. Chatterjee G, Roy D, Khemka VK, Chattopadhyay M, Chakrabarti S. 
Genistein, the isoflavone in soybean, causes amyloid beta peptide accu-
mulation in human neuroblastoma cell line: implications in Alzheimer’s 
disease. Aging Dis. 2015;6(6):456–65.
 14. Ogura Y, Sato K, Kawashima K, Kobayashi N, Imura S, Fujino K, Kawaguchi 
H, Nedachi T. Subtoxic levels of hydrogen peroxide induce brain-derived 
neurotrophic factor expression to protect PC12 cells. BMC Res Notes. 
2014;7:840.
 15. Tsai YC, Lee YM, Lam KK, Lin JF, Wang JJ, Yen MH, Cheng PY. The role of 
heat shock protein 70 in the protective effect of YC-1 on β-amyloid-
induced toxicity in differentiated PC12 cells. PLoS ONE. 2013;8(7):e69320.
 16. Horiuchi M, Maezawa I, Itoh A, Wakayama K, Jin LW, Itoh T, Decarli C. Amy-
loid beta1-42 oligomer inhibits myelin sheet formation in vitro. Neurobiol 
Aging. 2012;33(3):499–509.
 17. Miguel-Hidalgo JJ, Vecino B, Fernandez-Novoa L, Alvarez A, Cacabelos 
R. Neuroprotective role of S12024 against neurodegeneration in the rat 
dentate gyrus. Eur Neuropsychopharmacol. 1998;8(3):203–8.
 18. Papa S, Skulachev VP. Reactive oxygen species, mitochondria, apoptosis 
and aging. Mol Cell Biochem. 1997;174(1–2):305–19.
 19. Yin KJ, Lee JM, Chen SD, Xu J, Hsu CY. Amyloid-beta induces Smac 
release via AP-1/Bim activation in cerebral endothelial cells. J Neurosci. 
2002;22(22):9764–70.
 20. Minami M, Jin KL, Li W, Nagayama T, Henshall DC, Simon RP. Bcl-w expres-
sion is increased in brain regions affected by focal cerebral ischemia in 
the rat. Neurosci Lett. 2000;279(3):193–5.
 21. Yao M, Nguyen TV, Pike CJ. Estrogen regulates Bcl-w and Bim expression: 
role in protection against beta-amyloid peptide-induced neuronal death. 
J Neurosci. 2007;27(6):1422–33.
 22. Putcha GV, Moulder KL, Golden JP, Bouillet P, Adams JA, Strasser A, John-
son EM. Induction of BIM, a proapoptotic BH3-only BCL-2 family member, 
is critical for neuronal apoptosis. Neuron. 2001;29(3):615–28.
 23. Whitfield J, Neame SJ, Paquet L, Bernard O, Ham J. Dominant-negative 
c-Jun promotes neuronal survival by reducing BIM expression and inhib-
iting mitochondrial cytochrome c release. Neuron. 2001;29(3):629–43.
 24. Becker EB, Howell J, Kodama Y, Barker PA, Bonni A. Characterization of the 
c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis. J 
Neurosci. 2004;24(40):8762–70.
 25. Hsu MF, Raung SL, Tsao LT, Kuo SC, Wang JP. Cellular localization of the 
inhibitory action of abruquinone A against respiratory burst in rat neutro-
phils. Br J Pharmacol. 1997;120(5):917–25.
 26. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic 
program in cell-free extracts: requirement for dATP and cytochrome c. 
Cell. 1996;86(1):147–57.
 27. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz 
RL, Simpson RJ, Vaux DL. Identification of DIABLO, a mammalian protein 
that promotes apoptosis by binding to and antagonizing IAP proteins. 
Cell. 2000;102(1):43–53.
 28. Nicholson DW. Caspase structure, proteolytic substrates, and function 
during apoptotic cell death. Cell Death Differ. 1999;6(11):1028–42.
 29. Wai MS, Liang Y, Shi C, Cho EY, Kung HF, Yew DT. Co-localization of hyper-
phosphorylated tau and caspases in the brainstem of Alzheimer’s disease 
patients. Biogerontology. 2009;10(4):457–69.
 30. Bozyczko-Coyne D, O’Kane TM, Wu ZL, Dobrzanski P, Murthy S, Vaught 
JL, Scott RW. CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway 
Page 9 of 9You et al. BMC Neurosci  (2017) 18:12 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
activation, promotes survival and blocks multiple events associated with 
Aβ-induced cortical neuron apoptosis. J Neurochem. 2001;77(3):849–63.
 31. Yarza R, Vela S, Solas M, Ramirez MJ. c-Jun N-terminal Kinase (JNK) signal-
ing as a therapeutic target for Alzheimer’s disease. Front Pharmacol. 
2016;6:321.
 32. Bagheri M, Joghataei MT, Mohseni S, Roghani M. Genistein ameliorates 
learning and memory deficits in amyloid β1-40 rat model of Alzheimer’s 
disease. Neurobiol Learn Mem. 2011;95(3):270–6.
 33. Wise PM, Dubal DB, Wilson ME, Rau SW, Liu Y. Estrogens: trophic 
and protective factors in the adult brain. Front Neuroendocrinol. 
2001;22(1):33–66.
 34. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix 
SL, Jones BN, Assaf AR, Jackson RD, et al. Estrogen plus progestin and the 
incidence of dementia and mild cognitive impairment in postmenopau-
sal women: the Women’s Health Initiative Memory Study: a randomized 
controlled trial. JAMA. 2003;289(20):2651–62.
 35. Bang OY, Hong HS, Kim DH, Kim H, Boo JH, Huh K, Mook-Jung I. Neuro-
protective effect of genistein against beta amyloid-induced neurotoxicity. 
Neurobiol Dis. 2004;16(1):21–8.
 36. Taku K, Melby MK, Takebayashi J, Mizuno S, Ishimi Y, Omori T, Watanabe S. 
Effect of soy isoflavone extract supplements on bone mineral density in 
menopausal women: meta-analysis of randomized controlled trials. Asia 
Pac J Clin Nutr. 2010;19(1):33–42.
 37. Sbarouni E, Iliodromitis EK, Zoga A, Theodorakis GN, Kremastinos DT. 
The effect of the phytoestrogen genistein on myocardial protection 
and preconditioning in hypercholesterolemia. Cardiovasc Drugs Ther. 
2007;21(5):399–400.
 38. Bagheri M, Roghani M, Joghataei MT, Mohseni S. Genistein inhibits aggre-
gation of exogenous amyloid-bata1-40 and alleviates astrogliosis in the 
hippocampus of rats. Brain Res. 2012;1429:145–54.
 39. Bagheri M, Rezakhani A, Nystrom S, Turkina MV, Roghani M, Ham-
marstrom P, Mohseni S. Amyloid beta1-40-induced astrogliosis and 
the effect of genistein treatment in rat: a three-dimensional confocal 
morphometric and proteomic study. PLoS ONE. 2013;8(10):e76526.
